- Report
- March 2024
- 189 Pages
Global
From €3257EUR$3,374USD£2,794GBP
€3619EUR$3,749USD£3,104GBP
- Report
- November 2023
- 250 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- September 2019
- 327 Pages
Global
From €4319EUR$4,475USD£3,705GBP
- Report
- July 2021
- 120 Pages
Global
From €2413EUR$2,500USD£2,070GBP
- Report
- March 2024
- 150 Pages
From €5009EUR$5,190USD£4,297GBP
- Report
- August 2022
- 111 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- February 2018
- 98 Pages
Asia Pacific
From €3716EUR$3,850USD£3,188GBP
- Report
- March 2019
United States
From €7717EUR$7,995USD£6,619GBP
- Report
- August 2023
- 103 Pages
Global
From €3500EUR$3,884USD£3,107GBP
- Report
- February 2024
- 179 Pages
Global
From €3475EUR$3,600USD£2,981GBP
Brachytherapy is a type of radiation therapy used to treat cancer. It involves the placement of radioactive sources directly into or near a tumor. Brachytherapy devices are used to deliver radiation to the tumor, while minimizing exposure to surrounding healthy tissue. These devices are typically used to treat cancers of the prostate, breast, head and neck, and gynecological organs.
Brachytherapy devices are typically classified into two categories: high-dose rate (HDR) and low-dose rate (LDR). HDR devices are used to deliver a high dose of radiation in a short period of time, while LDR devices are used to deliver a lower dose of radiation over a longer period of time. Both types of devices are used to treat a variety of cancers.
The brachytherapy device market is highly competitive, with a number of companies offering a variety of products. Some of the major players in the market include Varian Medical Systems, Elekta AB, C. R. Bard, Inc., IsoRay Medical, Inc., and Eckert & Ziegler BEBIG. Show Less Read more